Where does Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” ranks #23,118 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Obschestvo S Ogranichennoi Otvetstvennostyu “weldup”'s Innovation Score?

Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” has an Innovation Score of 36.1 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Obschestvo S Ogranichennoi Otvetstvennostyu “weldup”'s patent grant rate increasing or decreasing?

Obschestvo S Ogranichennoi Otvetstvennostyu “weldup”'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Obschestvo S Ogranichennoi Otvetstvennostyu “weldup”'s patents?

Obschestvo S Ogranichennoi Otvetstvennostyu “weldup”'s patents average 11.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Obschestvo S Ogranichennoi Otvetstvennostyu “weldup”

Q: How many patents does Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” hold?

Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” holds 12 US utility patents granted between 2016 and 2024, spanning 22 technology areas.

Q: What technology areas does Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” focus on?

Obschestvo S Ogranichennoi Otvetstvennostyu “weldup”'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 3 patents. Grants appear in 22 CPC subclasses total.

Q: How is the Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 12 granted patents across 22 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Obschestvo ranks #23,118 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 22 technology areas.

#23,118
of 50,000 US assignees by volume: Top 47%
by Innovation Score (36.1/100): 11.1
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23118 · Foreign Corporation #23,118 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,118/50,000
PHOTO-FINISH NuLabel
CPC-FOCUS A61P · 22 areas
INNOV-THIN 36.1/100
CLAIMS-PAR 11.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nulabel Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Marsupial Holdings · near

36
Bioptigen · near

36
Medrx · near

36
Neofect · near

36
Obschestvo S Ogranic… · this assignee

36
3D Lighting Innovati… · lowest

7

What this shows Obschestvo's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Obschestvo's grants concentrate

Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” is a focused PatentsView assignee: 22 CPC subclasses with 25% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2016. By volume, Obschestvo sits between Nulabel Technologies, Inc. and Omnimax International, Llc.

Nulabel

12
Numab Therapeutics

12
Nura Holdings Pty

12
Nxera Pharma UK

12
OCM

12
Officine Maccafer…

12
Oleon

12
Omnimax Internati…

12
Obschestvo S Ogra… ◀

12

What this shows Obschestvo holds 12 patents at rank #23,110, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Obschestvo

By rank, the assignees closest to #23,110 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Obschestvo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Obschestvo, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Medrx Co., Ltd. 36 Neofect Co., Ltd. 36 Bioptigen, Inc. 36 Marsupial Holdings, Inc. 36

Obschestvo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	8.3%
2017	2	16.7%
2018	1	8.3%
2019	2	16.7%
2020	3	25.0%
2022	1	8.3%
2024	2	16.7%

Which technologies does Obschestvo S Ogranichennoi Otvetstvennostyu “weldup” patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3

C07K - PEPTIDES 2

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2

E21B - EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS 2

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 2

G06F - ELECTRIC DIGITAL DATA PROCESSING 2

G01V - GEOPHYSICS; GRAVITATIONAL MEASUREMENTS; DETECTING MASSES OR OBJECTS; TAGS 1

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 1

F03D - WIND MOTORS 1

Y02B - CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS 1

H02K - DYNAMO-ELECTRIC MACHINES 1

F05B - INDEXING SCHEME RELATING TO WIND, SPRING, WEIGHT, INERTIA OR LIKE MOTORS, TO MACHINES OR ENGINES FOR LIQUIDS COVERED BY SUBCLASSES F03B, F03D AND F03G 1

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 1

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 1

Top 15 of 22 technology areas

Where it ranks

Overall rank by patents

#23,118

of 50,000 tracked assignees

Innovation Score

36.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.